期刊文献+

CIK/NK细胞4周培养过程中的CD27、CD28的表达及其意义 被引量:3

Changes of the expression of CD27 and CD28 on cytokine-induced killer cells and natural killer cells during four week cultivation
下载PDF
导出
摘要 目的:了解细胞因子诱导杀伤(CIK)细胞和自然杀伤(NK)细胞在培养过程中CD27和CD28的表达变化规律。方法:通过流式细胞仪检测CD3+CD56+CIK细胞以及CD3-CD56+NK细胞在4周培养过程中其上CD27和CD28的表达变化。结果:CD27在CIK和NK细胞上均于培养的第2周达到最高峰,分别为(44.57±4.07)%和(51.02±5.20)%,但之后逐步下降,在培养第4周降至30%左右的水平。CD28在CIK和NK细胞上分别是在第3周和第2周时达到表达的最高峰,为(4.40±0.66)%和(45.14±3.58)%,之后迅速下降,在培养第4周已经几乎消失。结论:根据CD27和CD28在CIK/NK细胞上的表达变化规律,CIK/NK细胞的收获时机以培养第3周为宜。 AIM: To investigate the changes of CD27 and CD28 expression on cytokine -induced killer(CIK) cells and natural killer(NK) cells during cultivation. METHODS: The mononuclear cells were treated with interleukin- 12( IL-2) ,IL- 7, IL- 15, stem cell factor and FLT3 ligand for four weeks. The CD27 and CD28 expression on CD3^+ CD56 ^+ CIK cells and CD3 - CD56 + NK cells were examined by flow cytometric analysis every week during four - week cultivation. RESULTS: The expression of CD27 on CIK and NK cells two weeks after cultivation reached the peak value at (44. 57±4. 07)% and(51.02 ±5.20)%, respectively. Then, their expression declined gradually to about 30% in the fourth week. The expression of CD28 on CIK and NK cells reached the peak at the third and the second week, the values were (4.40±0.66)% and (45.14 ± 3.58 )%, respectively, decreased rapidly and then were almost completely lost at the fourth week. CONCLUSION: According to the changes of expressions of CD27 and CD28 on CIK/NK ceils, optimal harvest time of cultured CIK/NK cells should be at the third week of cultivation.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2009年第3期525-528,共4页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.30500469) 广州科学仪器协作共用网基金资助项目(No.2006034)
关键词 细胞因子诱导杀伤细胞 自然杀伤细胞 CD27 CD28 过继免疫治疗 Cytokine - induced killer cells Natural killer cells CD27 CD28 Adoptive immunotherapy
  • 相关文献

参考文献19

二级参考文献22

  • 1迟小伟,刘杰.胃癌患者B7-CD28共刺激通路的研究[J].临床检验杂志,2005,23(2):106-107. 被引量:6
  • 2Janeway C A Jr,Bottomly K.Signals and signs for lymphocyte responses[J].Cell,1994,76(2):275-285.
  • 3Balzano C,Buonavista N.CTLA-4 and CD28:similar proteins,neighbouring genes[J].Int J Cancer,1992,7(Suppl):28-32.
  • 4June C H,Bluestone J A.The B7 and CD28 receptor families[J].Immunol Today,1994,15(7):321-331.
  • 5Linsley P S,Greene J L.Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes[J].J Exp Med,1992,176(6):1595-1604.
  • 6Ansari M J, Abdi R. Emerging immunomodulatory therapies targeting the co-stimulatory pathways for the prevention oftransplant rejection. IDrugs ,2003,6 (10) :964
  • 7Li TS, Ito H, Kajiwara K,et al. Long-term survival of xenografted neonatal cardiomyocytes by adenovirus-mediated CTLA4-Ig expression and CD40 blockade. Circulation, 2003,108(14) :1 760
  • 8Slavik JM, Hutchcroft JE, Bierer BE. CD28/CTLA4 and CD80/CD86 families: signaling and function. Immunol Res,1999,19(1) :1
  • 9Skov S, Bonyhadi M, Odum N, et al. IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells. J Immunol,2000,164 ( 7 ): 3 500
  • 10Blotta MH, Marshall JD, DeKruyff RH, et al. Cross-linking of the CD40 ligand on human CD4 + T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis. J Immunol ,1996,156(9) :3 133

共引文献46

同被引文献59

引证文献3

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部